18 Jan 2022
Midatech Pharma - Q-Sphera partnership with Janssen expanded
Midatech Pharma (Midatech) has announced the extension of its Q-Sphera R&D collaboration deal with Janssen, its European partner since July 2020. The extension includes further optimisation (bio delivery) of Janssen’s experimental monoclonal antibody (mAb), which Midatech had successfully encapsulated using its Q-Sphera technology, as announced in June 2021. The company has an existing three-asset collaboration agreement with Janssen (to develop long-acting injectable versions of its undisclosed ....
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Midatech Pharma - Q-Sphera partnership with Janssen expanded
- Published:
18 Jan 2022 -
Author:
Jyoti Prakash -
Pages:
2
Midatech Pharma (Midatech) has announced the extension of its Q-Sphera R&D collaboration deal with Janssen, its European partner since July 2020. The extension includes further optimisation (bio delivery) of Janssen’s experimental monoclonal antibody (mAb), which Midatech had successfully encapsulated using its Q-Sphera technology, as announced in June 2021. The company has an existing three-asset collaboration agreement with Janssen (to develop long-acting injectable versions of its undisclosed ....